The University of Maryland Medicine has partnered with digital health research company Vibrent Health to host the study on its platform, which is designed to collect participant data from surveys, genomics, biosamples, EHRs, wearables, and other sources. Study participants will utilize mail-in services to submit genetic samples and will complete surveys related to the study on their mobile devices or computers.
Read more at Health IT Analytics.